End-Stage Liver Disease (see End-Stage Liver Disease, [[End-Stage Liver Disease]])
Sepsis (see Sepsis, [[Sepsis]])
Trial of Midodrine During Recovery Phase in Septic Shock (Chest, 2016) [ MEDLINE]: midodrine decreases pressor use during the recovery phase of sepsis and may be associated with decreased ICU length of stay Hepatorenal Syndrome (see
Hepatorenal Syndrome, [[Hepatorenal Syndrome]])
Cardiovascular Adverse Effects
QT Prolongation without Definite Association with Torsade (see Torsade, [[Torsade]]) Other Adverse Effects
Feasibility, utility, and safety of midodrine during recovery phase from septic shock. Chest. 2016 Mar 4. pii: S0012-3692(16)41575-8. doi: 10.1016/j.chest.2016.02.657 [
Property of Kenneth J. Serio, MD. Author is not responsible for errors in content, site is for information purposes only.